Ángel Crespo López

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*

Ángel Crespo López, José A. Lorente, Jay S. Steingrub et al. · Critical Care Medicine · 2004 · 917 citations

Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713]

Bernd Muellejans, Ángel Crespo López, Michael H. Cross et al. · Critical Care · 2003 · 169 citations · Full text

Hydration and carbonation of monoclinic C₂S and C₃S studied by Raman spectroscopy

Jordi Ibáñez, Lluís Artús, R. Cuscó et al. · Journal of Raman Spectroscopy · 2006 · 151 citations · Full text

Engineering, Cement Manufacture, Chemistry +16

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*

Steven M. Opal, Pierre‐François Laterre, Edward Abraham et al. · Critical Care Medicine · 2004 · 145 citations

Benzodiazepine withdrawal syndrome after a benzodiazepine antagonist

Ángel Crespo López, Jesus Rebollo · Critical Care Medicine · 1990 · 14 citations

Addiction, Medicine, Rebound Effect +6